✦ LIBER ✦

13 INVITED Phase zero clinical-trials in oncology: a new paradigm for early drug development?

✍ Scribed by C.H. Takimoto

Book ID: 118623641
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 52 KB
Volume: 4
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(06)70018-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 0 clinical trials in oncology: a p

Phase 0 clinical trials in oncology: a paradigm shift for early drug development?

✍ Chris H. Takimoto 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 271 KB

Evolution of Clinical Trial Design in Ea

Evolution of Clinical Trial Design in Early Drug Development: Systematic Review of Expansion Cohort Use in Single-Agent Phase I Cancer Trials

✍ Manji, A.; Brana, I.; Amir, E.; Tomlinson, G.; Tannock, I. F.; Bedard, P. L.; Oz 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 130 KB

Early Drug Development (Strategies and R

Early Drug Development (Strategies and Routes to First-in-Human Trials) || Toxicology Program to Support Initiation of a Clinical Phase I Program for a New Medicine

✍ Cayen, Mitchell N. 📂 Article 📅 2010 🏛 John Wiley & Sons, Inc. ⚖ 564 KB

Genomics-based early-phase clinical tria

Genomics-based early-phase clinical trials in oncology: Recommendations from the task force on Methodology for the Development of Innovative Cancer Therapies

✍ Liu, Stephen V.; Miller, Vincent A.; Lobbezoo, Marinus W.; Giaccone, Giuseppe 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 331 KB

PCN106 Development of a Guidance for Inc

PCN106 Development of a Guidance for Including Patient-Reported Outcomes (PROs) in Late-Phase Adult Clinical Trials of Oncology Drugs for Comparative Effectiveness Research (CER)

✍ Basch, E.M.; Abernethy, A.P.; Mullins, C.D.; Spencer, M.R. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB